BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10

• Press Releases

  Ascelia Pharma Files New Patent Application for Orviglance

  November 10, 2025

   · 

  2 min read
• Press Releases

  Dupixent® (dupilumab) Pivotal Trial Met All Primary and Secondary Endpoints, Reducing Signs and Symptoms of Allergic Fungal Rhinosinusitis (AFRS); sBLA Accepted for FDA Priority Review

  November 10, 2025

   · 

  26 min read
• Press Releases

  ORYZON Reports Financial Results and Corporate Update for Quarter Ended September 30, 2025

  November 10, 2025

   · 

  20 min read
• Press Releases

  QIAGEN Unveils QIAsymphony Connect and Showcases New Precision Oncology Innovations at AMP 2025

  November 10, 2025

   · 

  7 min read
• Press Releases

  Press Release: ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis; sBLA accepted for FDA priority review

  November 10, 2025

   · 

  17 min read
• Press Releases

  Pelthos Therapeutics Acquires Xepi® (ozenoxacin) Cream, 1% and Announces $18 Million Private Convertible Notes Financing

  November 10, 2025

   · 

  9 min read
• Press Releases

  Biofrontera Inc. announces sale of license to Xepi® Antibiotic Cream to Pelthos Therapeutics Inc. for up to $10M

  November 10, 2025

   · 

  4 min read
• Press Releases

  Atea Pharmaceuticals Presents New Data Supporting the Fixed-Dose Combination of Bemnifosbuvir and Ruzasvir as a Potential Best-in-Class Regimen for Treatment of Hepatitis C Virus Infection at The Liver Meeting® 2025

  November 10, 2025

   · 

  11 min read
• Press Releases

  Barinthus Bio Reports Third Quarter 2025 Financial Results and Updates on Corporate Developments

  November 10, 2025

   · 

  17 min read
• Press Releases

  ALX Oncology Reports Third Quarter 2025 Financial Results and Provides Corporate Update

  November 10, 2025

   · 

  14 min read